CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
The US is the world's largest producer of bioethanol as renewable liquid fuel, with more than 200 commercial plants processing over 16 billion gallons per year. Plants typically use dry grind ...
Dairy supplier Arla claims ‘revolutionary’ new technology to separate milk into its different protein components opens the door to ‘infinite innovation possibilities’. Milk protein fractionation using ...
Takeda’s (NYSE: TAK) (TSE:4502) plasma-derived therapies (PDT) business, led by Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma Protein ...
Vol. 2, No. 3/4, SPECIAL ISSUE: THE QUALITY OF HEALTH CARE: TRANSACTIONS OF THE 7TH INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY FOR QUALITY ASSURANCE (1990), pp. 207-212 (6 pages) The use of ...
It has been widely reported that around one-third of all the food produced globally is wasted. René Floris, NIZO Food Research Division Manager and member of the FoodNavigator expert advisory panel, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback